ALBIO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. It operates through the Professional and Consumer segments. The Professional segment allows proper medical management of the patients. The Consumer segment permits general public to self-monitor. The company was founded by Larry Abensur, Thomas Lamy, and Thierry Paper on March 15, 2005 and is headquartered in Illkirch-Graffenstaden, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALBIO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company